L2 Asset Management, LLC Abb Vie Inc. Transaction History

L2 Asset Management, LLC

$326 Million
Q2 2024

A detailed history of L2 Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, L2 Asset Management, LLC holds 12,552 shares of ABBV stock, worth $2.53 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

12,552

Previous 6,634 89.21%

Holding current value

$2.53 Million

Previous $1.21 Million 78.15%

% of portfolio

0.66%

Previous 0.41%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $916,047 - $1.07 Million	5,918 Added 89.21%	12,552 $2.15 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $270,415 - $308,113	1,692 Added 34.24%	6,634 $1.21 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $629,657 - $709,142	4,576 Added 1250.27%	4,942 $765,000
Q3 2023 Nov 08, 2023	SELL	$133.59 - $154.65 $1.56 Million - $1.8 Million	-11,650 Reduced 96.95%	366 $54,000
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $221,689 - $275,877	1,673 Added 16.18%	12,016 $1.62 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $168,181 - $193,686	-1,163 Reduced 10.11%	10,343 $1.65 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $54,623 - $62,649	407 Added 3.67%	11,506 $1.54 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $223,357 - $283,960	1,623 Added 17.13%	11,099 $1.7 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $556,031 - $689,878	4,213 Added 80.05%	9,476 $1.54 Million
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $134,717 - $170,456	1,254 Added 31.28%	5,263 $713,000
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $102,144 - $115,948	-960 Reduced 19.32%	4,009 $432,000
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $128,040 - $142,644	-1,217 Reduced 19.67%	4,969 $560,000
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $523,878 - $576,727	-5,121 Reduced 45.29%	6,186 $669,000
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $186,173 - $251,353	-2,313 Reduced 16.98%	11,307 $1.21 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $1.1 Million - $1.29 Million	-12,812 Reduced 48.47%	13,620 $1.19 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $56,054 - $75,009	764 Added 2.98%	26,432 $2.6 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $465,883 - $706,337	7,223 Added 39.16%	25,668 $1.96 Million
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $1.33 Million - $1.66 Million	18,445 New	18,445 $1.63 Million

Others Institutions Holding ABBV

# of Institutions

3,778

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $357B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of L2 Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on L2 Asset Management, LLC with notifications on news.

Account

L2 Asset Management, LLC Abb Vie Inc. Transaction History